KVUE
Kenvue Inc (KVUE)
Consumer Defensive • NYSE • $17.59-0.73%
- Symbol
- KVUE
- Exchange
- NYSE
- Sector
- Consumer Defensive
- Industry
- Household & Personal Products
- Price
- $17.59
- Daily Change
- -0.73%
- Market Cap
- $33.77B
- Trailing P/E
- 20.94
- Forward P/E
- 14.21
- 52W High
- $24.61
- 52W Low
- $14.02
- Analyst Target
- $19.50
- Dividend Yield
- +4.72%
- Beta
- 0.52
Kenvue Inc. operates as a consumer health company in the United States, rest of North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates in three segments: Self Care, Skin Health and Beauty, and Essential Health. The company offers over-the-counter medicine for cough, cold and allergy, pain care, digestive health, smoking cessation, and eye care, as well as other naturally inspired and self-care products, digital diagnostics, and telemedicine; face and body care, hair, sun, and other care products; oral and baby care, women's health, wound care, and other essential health products; tampons; cosmetics; and vitamins and supplements. It sells its products under the Benadryl, Calpol, Motrin, Nicorette, Rhinocort, Tylenol, Zarbee's Naturals, and Zyrtec; A…
Company websiteResearch KVUE on Stk-Ai
Stk-Ai gives you screening across 100+ fundamental metrics, AI-powered analysis, target predictions, backtested signals, and portfolio tracking — all in one place.
Data shown is for informational purposes only and is not investment advice. Prices and metrics may be delayed.